Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma

Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma

High-dose melphalan followed by autologous stem cell transplantation (ASCT) remains the standard of care for fit patients with multiple myeloma (MM). However, individuals who are dependent on hemodialysis are frequently excluded from ASCT. Recommendations on chemotherapy dosing and hemodialysis sche...

Full description

Saved in:
Bibliographic Details
Main Authors: Rabea Mecklenbrauck, Bernhard M.W. Schmidt, Heike Bähre, Annamaria Brioli, Arnold Ganser, Florian H. Heidel, Felicitas Thol
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Leukemia Research Reports
Subjects:
Multiple myeloma
Autologous stem cell transplantation
High-dose melphalan
Hemodialysis
Online Access:http://www.sciencedirect.com/science/article/pii/S221304892500024X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items